Content Curator | Updated on - Mar 30, 2026

The MD (Pharmacology) at Veer Surendra Sai Institute of Medical Sciences and Research (VIMSAR), Burla, is a 3-year full-time postgraduate medical degree programme offered on campus. With a seat intake of 7 seats, the course provides comprehensive training in general pharmacology, clinical pharmacology, drug development, pharmacokinetics, pharmacodynamics, and rational drug use. The total course fees for the General category is Rs. 93,500 for the entire 3-year duration, making it one of the most affordable government PG medical programmes in India. Admission is strictly through NEET PG, and the course is valued for its strong research orientation and excellent career prospects in academia, pharmaceutical industry, clinical research, and regulatory affairs.

As of March 2026, the Odisha State PG Medical Counselling (PGMCC) for the 2026-27 session has been completed through Round 4 (Stray Vacancy Round), with the final admission list published on February 25, 2026. For the upcoming 2026-27 session, admissions will be based on NEET PG 2026, with the exam tentatively scheduled for June 15, 2026. Odisha State PG counselling for 2026-27 is expected to commence from October-November 2026 after NEET PG 2026 results are declared.

Key Points

MD Pharmacology at VIMSAR offers 7 seats and covers general pharmacology, clinical pharmacology, drug development, pharmacokinetics, and rational drug use.
The course is particularly suited for candidates interested in pharmaceutical research, clinical trials, drug regulatory affairs, and academic careers in medical colleges.
VIMSAR is a government institution under the Government of Odisha, offering highly subsidised fees compared to private and deemed universities.
PG students at VIMSAR receive a monthly stipend of approximately Rs. 70,000 to Rs. 72,000, significantly offsetting living costs.
A bond obligation applies: students must serve for 2 years post-completion, with a penalty equivalent to double the total stipend received if the bond is broken.
MD Pharmacology has a relatively accessible NEET PG cutoff compared to clinical branches, making it a viable option for a wider range of candidates.

Official Link:

Go To Website

Highlights
Fees
Admission
Scholarships
Cutoff
Ranking
FAQs

VIMSAR Latest Updates and News

15 Apr, 2026 NEET PG 2026 Registrations are expected to begin in the Last Week of April at nbe.edu.in. Exam on August 30, 2026. Read Full News.

VIMSAR MD Pharmacology Fees

VIMSAR offers the MD (Pharmacology) programme at a very nominal fee as a government medical college. The total academic fee for the entire 3-year course is Rs. 93,500 for the General category, which includes tuition fees of Rs. 75,000 spread equally over three years at Rs. 25,000 per year. One-time charges such as admission fee, registration fee, and caution deposit are payable only in the first year. Hostel accommodation is available separately at an additional cost.

Fee Structure

Fee Component	Year 1 (INR)	Year 2 (INR)	Year 3 (INR)	Total (INR)
Tuition Fees	25,000	25,000	25,000	75,000
Admission Fees	2,000	-	-	2,000
Registration Fees	300	-	-	300
Caution Fee	10,000	-	-	10,000
Library Fees	600	600	600	1,800
Miscellaneous Fees	2,400	1,000	1,000	4,400
Yearly Total	40,300	26,600	26,600	-
Total Academic Fees	-	-	-	93,500
Hostel Fees (per year)	4,730 to 14,000	4,730 to 14,000	4,730 to 14,000	14,190 to 42,000 (approx.)
Total Fees (with Hostel)	-	-	-	~1,07,690 to 1,35,500

Caution Fee of Rs. 10,000 is refundable at the time of leaving the institution.
Hostel accommodation is optional and not mandatory; hostel fees are charged separately.
PG students receive a monthly stipend of Rs. 70,000 to Rs. 72,000, which substantially covers living and other expenses.
No EMI options are typically available for government college fees given the low fee structure.

VIMSAR MD Pharmacology Admission 2026

Admission to MD (Pharmacology) at VIMSAR is based on NEET PG scores. Seats are filled through two routes: All India Quota (AIQ) via MCC counselling and State Quota via Odisha PGMCC counselling conducted by DMET Odisha. For the 2026-27 session, the Odisha state counselling has been completed across four rounds, with the final admission list published in February 2026. For the 2026-27 session, admissions will be based on NEET PG 2026 results.

College/Counselling Dates

Event	Date
Odisha PGMCC Online Registration Opens	October 30, 2025
Document Verification	November 2025
Provisional Merit List Publication	November 19, 2025
Seat Matrix Publication (Round 1)	November 20-22, 2025
Round 1 Allotment	November 27, 2025
Round 2 Schedule Announced	December 9, 2025
Round 2 Allotment	December 21, 2025
Round 3 Registration Opens	January 17, 2026
Round 3 Physical Counselling	February 2026
Round 4 (Stray Vacancy) Counselling	February 19-23, 2026
Final Admission List Published	February 25, 2026
Last Date of Joining (AIQ Stray Vacancy)	February 28, 2026

NEET PG 2026 Exam Dates

Event	Date
NEET PG 2026 Registration Start	April 7, 2026 (Tentative)
NEET PG 2026 Registration End	May 7, 2026 (Tentative)
NEET PG 2026 Admit Card	June 11, 2026 (Tentative)
NEET PG 2026 Exam Date	June 15, 2026 (Tentative)
NEET PG 2026 Result	July 15, 2026 (Tentative)
Odisha PGMCC 2026-27 Counselling (Expected)	October-November 2026 (Tentative)

The dates mentioned above are tentative and subject to change.

Eligibility Criteria:

Candidates must hold an MBBS degree from a recognised university/institution approved by the National Medical Commission (NMC).
Candidates must have a valid NEET PG score and must have completed their compulsory rotating internship (CRRI) before the date of joining.
For State Quota seats, candidates must be domicile of Odisha or fulfil the state-specific eligibility criteria as per DMET Odisha guidelines.

Admission Process:

Appear in NEET PG conducted by NBEMS and obtain a valid score.
Register for MCC AIQ counselling (for All India Quota seats) or Odisha PGMCC counselling (for State Quota seats).
Submit documents for verification as per the counselling schedule.
Participate in choice filling and seat allotment rounds.
Report to VIMSAR with original documents and pay the requisite fees within the stipulated joining deadline.
Execute the bond as per DMET Odisha norms before joining.

VIMSAR MD Pharmacology Scholarships 2026

PG medical students at VIMSAR can avail scholarships and financial support primarily through state government schemes. The most significant financial benefit is the monthly stipend of Rs. 70,000 to Rs. 72,000 provided to all PG students, which is a service-linked remuneration. Additionally, Odisha government scholarships are available for eligible students based on merit and income criteria.

Scholarship Details

Scholarship	Eligibility	Amount	Offered By
Medhabruti Scholarship (PG Merit)	Odisha domicile; merit in qualifying exam; family income up to Rs. 6 lakh per annum	Rs. 20,000 per year (PG Merit)	Government of Odisha
Post-Matric Scholarship (SC/ST)	SC/ST category students; Odisha domicile	As per government norms	Government of Odisha / Central Government
Monthly Stipend (PG Students)	All enrolled PG students at VIMSAR	Rs. 70,000 to Rs. 72,000 per month	Government of Odisha / VIMSAR

The Medhabruti Scholarship is applicable to Odisha domicile students only and must be applied through the State Scholarship Portal (scholarship.odisha.gov.in).
SC/ST students may also be eligible for central government post-matric scholarships; applications are made through the National Scholarship Portal (scholarships.gov.in).
The monthly stipend is subject to bond conditions; students who break the bond must repay double the total stipend received.
Application deadlines for state scholarships are typically announced in the first quarter of the academic year.

VIMSAR M.D Pharmacology Ranking

Collegedunia Ranking

#199 out of 632 in India 2025

#5th in Odisha

Do you think the Rankings are wrong ? Report Here

VIMSAR MD Pharmacology FAQs

Ques. How many seats are available for MD Pharmacology at VIMSAR Burla?

Ans. VIMSAR offers 7 seats for MD Pharmacology. These seats are divided between All India Quota (AIQ) and Odisha State Quota. The AIQ seats are filled through MCC counselling, while state quota seats are filled through Odisha PGMCC conducted by DMET Odisha.

Ques. What is the NEET PG cutoff rank for MD Pharmacology at VIMSAR?

Ans. Based on 2024 MCC AIQ counselling data, the closing rank for the General category ranged from 28,062 to 59,688 across rounds, for OBC it was 89,496 to 92,344, and for SC it was 63,422 to 1,47,167. In 2023, the General category closing rank ranged from 55,443 to 76,400. These ranks vary each year depending on the number of candidates and seat availability.

Ques. What career options are available after MD Pharmacology from VIMSAR?

Ans. Graduates of MD Pharmacology can pursue careers in academia as faculty in medical colleges, work in pharmaceutical companies in drug development and clinical research roles, join regulatory bodies like CDSCO, work in clinical research organisations (CROs), or take up positions in government health departments. The field has growing demand due to the expanding pharmaceutical and biotech industry in India.

Ques. Is there a bond obligation for MD Pharmacology students at VIMSAR?

Ans. Yes. All PG students at VIMSAR are required to sign a bond as per DMET Odisha norms. The bond requires students to serve for 2 years after completing the course. If the bond is broken, the penalty is equivalent to double the total stipend received during the course.

Ques. What is the monthly stipend for MD Pharmacology students at VIMSAR?

Ans. PG students at VIMSAR receive a monthly stipend of approximately Rs. 70,000 to Rs. 72,000. This stipend is provided by the Government of Odisha and is linked to the bond obligation.

Ques. Is MD Pharmacology a good option for candidates interested in the pharmaceutical industry?

Ans. Yes. MD Pharmacology is one of the best PG options for MBBS graduates who wish to transition into the pharmaceutical industry, clinical research, or drug regulatory affairs. The degree is recognised by the NMC and opens doors to roles in drug development, pharmacovigilance, medical affairs, and clinical trial management at pharmaceutical companies and CROs.